| Product Code: ETC12838738 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Influenza Vaccines Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Influenza Vaccines Market - Industry Life Cycle |
3.4 Japan Influenza Vaccines Market - Porter's Five Forces |
3.5 Japan Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Japan Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 Japan Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Japan Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Japan Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination in Japan |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing elderly population in Japan, who are more susceptible to influenza |
4.3 Market Restraints |
4.3.1 Limited availability of vaccines during peak flu seasons |
4.3.2 High cost of vaccines leading to affordability issues for some segments of the population |
5 Japan Influenza Vaccines Market Trends |
6 Japan Influenza Vaccines Market, By Types |
6.1 Japan Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Japan Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 Japan Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 Japan Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 Japan Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 Japan Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 Japan Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 Japan Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Japan Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Japan Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Japan Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Japan Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Japan Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 Japan Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 Japan Influenza Vaccines Market Import-Export Trade Statistics |
7.1 Japan Influenza Vaccines Market Export to Major Countries |
7.2 Japan Influenza Vaccines Market Imports from Major Countries |
8 Japan Influenza Vaccines Market Key Performance Indicators |
8.1 Rate of vaccination coverage among target populations |
8.2 Number of public health campaigns promoting influenza vaccination |
8.3 Research and development investments in new vaccine technologies |
8.4 Number of reported influenza cases in Japan |
8.5 Percentage of healthcare professionals recommending influenza vaccination |
9 Japan Influenza Vaccines Market - Opportunity Assessment |
9.1 Japan Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Japan Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 Japan Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Japan Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Japan Influenza Vaccines Market - Competitive Landscape |
10.1 Japan Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Japan Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here